Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. (Q53531493)
Jump to navigation
Jump to search
scientific article published in February 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. |
scientific article published in February 2000 |
Statements
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. (English)
D Fairclough
P Bonomi
K Kim
D Cella
J Kugler
E Rowinsky
M Jiroutek
D Johnson
1 February 2000
18
3
623-631